153 related articles for article (PubMed ID: 26139648)
21. An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors.
Kjeldsen S; Mancia G; Schmieder R; Mattheus M; Unger T
Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):673-82. PubMed ID: 23750676
[TBL] [Abstract][Full Text] [Related]
22. Warnings against candesartan in pregnancy are not implemented in physicians' practice.
Borthen C; Oglaend B; Eggebøe T; Ellingsen CL; Schjøtt J
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):235. PubMed ID: 19615811
[No Abstract] [Full Text] [Related]
23. A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD): Biomarker study.
Ogawa H; Soejima H; Matsui K; Kim-Mitsuyama S; Yasuda O; Node K; Yamamuro M; Yamamoto E; Kataoka K; Jinnouchi H; Sekigami T;
Eur J Prev Cardiol; 2016 Jun; 23(9):913-21. PubMed ID: 26324672
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
Nalbantgil I; Nalbantgil S; Ozerkan F; Yilmaz H; Gürgün C; Zoghi M; Aytimur M; Onder R
Int J Clin Pract Suppl; 2004 Dec; (145):50-4. PubMed ID: 15617460
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.
Sharma A; Baliga V;
J Indian Med Assoc; 2008 Mar; 106(3):191-4, 196. PubMed ID: 18712142
[TBL] [Abstract][Full Text] [Related]
26. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
Guthrie RM
Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454
[TBL] [Abstract][Full Text] [Related]
27. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
[TBL] [Abstract][Full Text] [Related]
28. Telmisartan.
Bakheit AH; Abd-Elgalil AA; Mustafa B; Haque A; Wani TA
Profiles Drug Subst Excip Relat Methodol; 2015; 40():371-429. PubMed ID: 26051689
[TBL] [Abstract][Full Text] [Related]
29. Importance of a fixed combination of telmisartan and amlodipine for the treatment of hypertension.
Ahrens K; Bramlage P
Drugs Today (Barc); 2010 May; 46(5):339-50. PubMed ID: 20517535
[TBL] [Abstract][Full Text] [Related]
30. Course and outcome of pregnancy after maternal exposure to angiotensin-II-receptor blockers--case report and review of the literature.
Enzensberger C; Eskef K; Schwarze A; Faas D; Axt-Fliedner R
Ultraschall Med; 2012 Oct; 33(5):493-6. PubMed ID: 21630188
[No Abstract] [Full Text] [Related]
31. [New studies on hypertension of great significance to clinical practice. Also very old persons benefit from blood pressure reduction].
Nilsson PM
Lakartidningen; 2008 May 7-13; 105(19):1382-4. PubMed ID: 18574975
[No Abstract] [Full Text] [Related]
32. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study.
Ihm SH; Jeon HK; Cha TJ; Hong TJ; Kim SH; Lee NH; Yoon JH; Yoon N; Hwang KK; Jo SH; Youn HJ
Drug Des Devel Ther; 2016; 10():3817-3826. PubMed ID: 27920497
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
[TBL] [Abstract][Full Text] [Related]
34. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Oparil S; Kjeldsen SE; Hedner T; Narkiewicz K
Blood Press; 2009; 18(1-2):4-6. PubMed ID: 19191085
[No Abstract] [Full Text] [Related]
35. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.
Pucci M; Sarween N; Knox E; Lipkin G; Martin U
Expert Rev Clin Pharmacol; 2015 Mar; 8(2):221-31. PubMed ID: 25612630
[TBL] [Abstract][Full Text] [Related]
36. [Transient renal failure in a newborn due angiotensin receptor II antagonist use during pregnancy: report of a case].
Hasbún H J; Valdés R E; San Martín O A; Catalán M J; Salinas Q S; Parra C M
Rev Med Chil; 2008 May; 136(5):624-30. PubMed ID: 18769811
[TBL] [Abstract][Full Text] [Related]
37. [Clinical profiles of new angiotensin II receptor blockers: telmisartan, olmesartan medoxomil, and irbesartan].
Ishii M
Nihon Rinsho; 2004 Jan; 62(1):193-202. PubMed ID: 14737853
[TBL] [Abstract][Full Text] [Related]
38. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.
Polifka JE
Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):576-98. PubMed ID: 22807387
[TBL] [Abstract][Full Text] [Related]
39. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R
Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
[TBL] [Abstract][Full Text] [Related]
40. A complicated role for the renin-angiotensin system during pregnancy: highlighting the importance of drug discovery.
Darby M; Martin JN; LaMarca B
Expert Opin Drug Saf; 2013 Nov; 12(6):857-64. PubMed ID: 23915333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
